The American Board of Ophthalmology Tie.

This article discusses the efforts of the American Board of Ophthalmology (ABO) to recognize and celebrate the contributions of its volunteers to certification programs and processes. In recognition of service to the ABO, all directors and examiners received ties for men and scarves for women bearing the ABO logo and colors. This article briefly describes the rationale and the importance of these articles for those who receive them.

The role of latanoprost in an inflammatory bowel disease flare.

Ulcerative colitis and Crohn's disease (CD) are characterized by inflammation of the intestinal mucosa and symptoms of abdominal pain and diarrhea. Many studies have shown an association between elevated levels of prostaglandins and mucosal damage in inflammatory bowel disease. We report a 50-year-old woman with a history of CD and open-angle glaucoma.

Effect of brimonidine on retinal vascular autoregulation and short-term visual function in normal tension glaucoma.

Purpose: To assess whether brimonidine 0.15% alters retinal vascular autoregulation and short-term visual function in normal tension glaucoma patients who demonstrate retinal vascular dysregulation.

Design: Nonrandomized clinical trial.

Repeat selective laser trabeculoplasty.

Purpose: To evaluate the efficacy of repeat 360-degree selective laser trabeculoplasty (SLT) in glaucoma patients with prior successful 360-degree SLT.

Design: Retrospective chart review.

Methods: Forty-four eyes of 35 patients, > or =18 years of age, with open-angle glaucoma (primary open-angle, pseudoexfoliation, or pigmentary glaucoma), uncontrolled on maximum tolerable medical therapy, underwent an initial 360-degree SLT (SLT1), which was successful for > or =6 months, but eventually lost efficacy and was followed by a repeat 360-degree SLT (SLT2).

Evaluation of a modified protocol for selective laser trabeculoplasty.

Purpose: To compare the intraocular pressure (IOP) response to a modified protocol for selective laser trabeculoplasty (SLT) to standard protocols for SLT and argon laser trabeculoplasty (ALT).

Materials And Methods: A retrospective study of 318 eyes of 284 patients diagnosed with either primary open angle, pigmentary or pseudoexfoliation glaucoma who underwent laser trabeculoplasty from September 1997 to September 2005. One hundred and two patients, who underwent a modified SLT protocol with 100 overlapping laser spots over 180 degrees of trabecular meshwork were compared with 89 patients who received SLT with 100 nonoverlapping spots over 360 degrees and another 127 patients who received ALT with 50 spots over 180 degrees.

Patients' and physicians' perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension.

Objective: This study describes patients' and physicians' perceptions of issues related to dosing adherence with topical therapies for lowering intraocular pressure before and after use of the travoprost dosing aid (Travatan Dosing Aid, Alcon Research Ltd., Fort Worth, Texas).

Methods: The study had an open-label, multicenter, single-treatment-arm design that included sequential patients with open-angle glaucoma (with or without pigment dispersion or pseudoexfoliation component) or ocular hypertension who were taking any prostaglandin analogue monotherapy.

The influence of peripheral iridotomy on the intraocular pressure course in patients with pigmentary glaucoma.

Purpose: To evaluate the influence of laser peripheral iridotomy on the long-term intraocular pressure course for patients with pigmentary glaucoma.

Patients And Methods: Retrospective analysis of data contributed by members of the American Glaucoma Society on patients with bilateral pigmentary glaucoma, who received uniocular laser iridotomy. The main outcome measure was the post-laser intraocular pressure course of the treated eyes, compared with the fellow, untreated eyes.

Needle revision of failed filtering blebs using 5-Fluorouracil and a combined ab-externo and ab-interno approach.

Purpose: To evaluate a surgical technique to revise a failed filtering bleb using subconjunctival 5-Fluorouracil with a combined ab-externo and ab-interno approach.

Patients And Methods: This study is a retrospective review of the outcome of 77 consecutive bleb revisions, with greater than 6-month follow-up, performed by a single glaucoma surgeon (MW). All eyes had previously functioning filtering blebs with currently inadequately controlled intraocular pressures (IOP) prior to the bleb revisions.

Increased periocular pigmentation with ocular hypotensive lipid use in African Americans.

Purpose: To report increased eyelid pigmentation as an adverse side effect associated with topical ocular hypotensive lipids in African Americans.

Design: Interventional case series.

Methods: Two African-American patients with open-angle glaucoma are described in whom increased eyelid pigmentation developed 1 month to 5 months after beginning treatment with either latanoprost or bimatoprost.

Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.

Objective: To compare the efficacy and safety of timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.

Cystoid macular edema in the era of ocular hypotensive lipids.

Purpose: To review cystoid macular edema in relationship with ocular hypotensive lipids and to present recommendations for use in eyes at increased risk of cystoid macular edema.

Design: Focused literature review and authors' clinical experience.

Methods: Cystoid macular edema in association with cataract surgery, epinephrine therapy, and ocular hypotensive lipid therapy is reviewed.

Cystoid macular edema associated with ocular hypotensive lipids.

Purpose: To report angiographically documented cystoid macula edema associated with the use of each of the three newly available ocular hypotensive lipids: unoprostone, travaprost, and bimatoprost.

Design: Observational case series.

Methods: Retrospective review of three patients in a clinical practice who had uncontrolled glaucoma on maximal tolerable therapy except for an ocular hypotensive lipids.